HOME >> BIOLOGY >> NEWS
Blood test may help signal tumor's remission, return in throat cancer patients

A blood test that detects proteins commonly released by a growing tumor could one day become a useful tool for monitoring the effectiveness of chemotherapy and radiation treatment in people with advanced throat cancer, according to a study published in the June 1, 2007, issue of Clinical Cancer Research. Scientists in the National Institute on Deafness and Other Communication Disorders (NIDCD) and National Cancer Institute (NCI), two of the National Institutes of Health (NIH), in collaboration with researchers of the University of Michigan, found that throat cancer patients who showed a decline in several cancer-related proteins following chemotherapy and radiation treatment were more likely to remain in remission, while those who experienced a large rise over time in those proteins frequently exhibited a return of throat cancer. The findings could help lead to the development of a blood test that enables doctors to detect the recurrence of throat cancer early on, when there is still time to pursue a second line of treatment, such as surgery or drug therapy.

Cancers of the head and neck are insidious because surgical removal of the tumor can severely impair a persons ability to talk and to swallow, said NIDCD Director, James F. Battey, Jr., M.D., Ph.D. A blood test that enables doctors to closely monitor a patients rehabilitation while sparing the patients voice, speech, and swallowing ability is an excellent example of the predictive, preemptive, and personalized approach to medicine that the NIH strives for.

Roughly 20 years ago, the primary method for treating throat cancer was to surgically remove the tumor. Because this treatment can severely impair a patients quality of life by damaging voice, speech, and swallowing, in many cases physicians and their patients are now opting for a combination of chemotherapy and radiation as a first line of treatment. However, there is no way to predict which patients will respond well to this tr
'"/>

Contact: Patricia Blessing
blessinp@mail.nih.gov
301-496-7243
NIH/National Institute on Deafness and Other Communication Disorders
1-Jun-2007


Page: 1 2 3 4

Related biology news :

1. Blood sugars manufacture limited by building blocks supply
2. Bloods clotting cells harbor ticking time bombs, finding may help extend blood supply
3. Blood tests may be possible for mental health conditions
4. Cord Blood Registry achieves industry-leading stem cell recovery with new automation technology
5. Blood test predicts cardiac events and death in heart patients
6. Blood clot fibers more elastic than spiders web
7. Blood-compatible nanoscale materials possible using heparin
8. Blood pressure medication may revolutionize treatment of Marfan syndrome
9. Blood levels of suspected carcinogen vary by race, ethnicity
10. Blood conservation strategies take center stage at Emory University Hospital forum
11. Blood test for colon cancer risk to be goal of Hopkins project

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2019)... (PRWEB) , ... October 04, 2019 , ... ... 2019 will be held November 10 at the Grand Elysée Hamburg Rothenbaumchaussee in ... to Europe again this November,” said Miao Guo, Vice President of Operations and ...
(Date:10/3/2019)... , ... October 02, 2019 , ... ... source of financing and ongoing support for Connecticut’s innovative, growing companies, today announced ... protection company for mobile payments and winner of the 2018 VentureClash ...
(Date:9/30/2019)... ... September 30, 2019 , ... ... supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announced ... to “Ready-to-Print” (RTP) cellular product formats (patent number AU 2015259373). This new ...
Breaking Biology News(10 mins):
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia ... therapy technology (“3LT®”), today announces that the U.S. Food and Drug Administration (FDA) ... laser for the temporary relief of chronic neck and shoulder pain of musculoskeletal ...
(Date:10/3/2019)... Ariz. (PRWEB) , ... October 01, 2019 , ... ... your brain relax and reset itself, announced the midway point of its randomized ... objective of the study is to measure the efficacy of a non-invasive technology ...
(Date:10/3/2019)... , ... October 02, 2019 , ... ... life sciences leadership firm that is enabling clinical program outsourcing success by cultivating ... by award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings clients deep, ...
(Date:10/3/2019)... ... October 02, 2019 , ... eKare’s inSight® digital 3D imaging ... Accelerator run by the East Midlands Academic Health Science Network (EMAHSN), the innovation arm ... in NHS by providing support to develop and deploy solutions to the most pressing ...
Breaking Biology Technology:
Cached News: